---
title: "Mesoblast Financial Results and Corporate Update Webcast"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296779477.md"
description: "On August 24, 2026, Mesoblast Limited, a leading global company specializing in allogeneic cellular medicines for inflammatory conditions and listed on ASX under the symbol MSB and Nasdaq under MESO, will be conducting a webcast to review operational achievements and financial outcomes for the complete year closing on June 30, 2026."
datetime: "2026-08-24T11:02:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296779477.md)
  - [en](https://longbridge.com/en/news/296779477.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296779477.md)
generator: "portal-rs"
---

# Mesoblast Financial Results and Corporate Update Webcast

On August 24, 2026, Mesoblast Limited, a leading global company specializing in allogeneic cellular medicines for inflammatory conditions and listed on ASX under the symbol MSB and Nasdaq under MESO, will be conducting a webcast to review operational achievements and financial outcomes for the complete year closing on June 30, 2026.

### Related Stocks

- [MESO.US](https://longbridge.com/en/quote/MESO.US.md)
- [MSB.AU](https://longbridge.com/en/quote/MSB.AU.md)

## Related News & Research

- [Dotz Nano Redeems Convertible Notes, Streamlines Capital Structure](https://longbridge.com/en/news/296859835.md)
- [The Calmer Co. Details ASX Governance Compliance in Appendix 4G Filing](https://longbridge.com/en/news/297454626.md)
- [ImpediMed lodges 2026 Corporate Governance Statement and Appendix 4G](https://longbridge.com/en/news/297105943.md)
- [Minerals 260 Plans New Share Placement on ASX](https://longbridge.com/en/news/297256901.md)
- [Borsa Italiana clears ICOP for Euronext Milan listing as Growth Milan exit looms](https://longbridge.com/en/news/297540660.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**